Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms Deuterated [18F]hexadeuterofluoropropyl-(+)-dihydrotetrabenazine, FLUORINE-18 P17 059, [18F]D6-FP-DTBZ + [1] |
Target |
Mechanism VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 1 | US | 15 Jul 2022 |